Diagnosis and Management of CIRCI in Critically Ill Patients (Part II)
Citation: Pastores SM, et al. Crit Care Med. 2018;46:146-148.
The Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) jointly published guidelines in 2017 for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients. This part II of the guidelines is related to acute illnesses that may be complicated by CIRCI.
Guideline Type: Clinical
Related Resources:
Identifier:
Strength:
We suggest the use of corticosteroids for 5−7 days at a daily dose < 400 mg IV hydrocortisone or equivalent in hospitalized patients with CAP.
Quality of evidence: Moderate
We suggest against the use of corticosteroids in adults with influenza.
Quality of evidence: Very low
We recommend use of corticosteroids in patients with bacterial meningitis.
Quality of evidence: Low
We suggest use of corticosteroids in patients undergoing cardiopulmonary bypass surgery.
Quality of evidence: Moderate
We suggest use of corticosteroids in the setting of cardiac arrest.
Quality of evidence: Very low
Abbreviations: CAP, community-acquired pneumonia.
